Markets

BrainsWay, Inland Psychiatric Collaborate On Multi-System Deep TMS Deployment And Mental Health Research Initiatives

Oct 19, 2026 · 07:34 AM ET· updated 1h ago

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced non-invasive neurostimulation treatments for mental health disorders, today announced a strategic

Why It Matters

BrainsWay is partnering with Inland Psychiatric to use and study brain treatment technology. This shows the company is growing its reach and testing new ways to help people.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

BWAY11.43

-0.39 (-3.30%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.